Irritable Bowel Syndrome -Epidemiology Forecast to 2027

Irritable Bowel Syndrome -Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "Irritable Bowel Syndrome (IBS) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Irritable Bowel Syndrome (IBS) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

Irritable Bowel Syndrome (IBS) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for Irritable Bowel Syndrome (IBS) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Irritable Bowel Syndrome (IBS) outlook. It also includes the explanation of changing trends of epidemiology outlining the Irritable Bowel Syndrome (IBS) scenario.

Irritable Bowel Syndrome (IBS) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Irritable Bowel Syndrome (IBS) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of Irritable Bowel Syndrome (IBS) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Irritable Bowel Syndrome (IBS) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in Irritable Bowel Syndrome (IBS)

Key assessments
• Patient Segmentation in Irritable Bowel Syndrome (IBS)
• Irritable Bowel Syndrome (IBS) Risk & Burden
• Factors driving growth in a specific Irritable Bowel Syndrome (IBS) patient population
1. Report Introduction
2. Irritable Bowel Syndrome (IBS) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Irritable Bowel Syndrome (IBS) in 2017
2.2. Patient Share Distribution of Irritable Bowel Syndrome (IBS) in 2027
3. Disease Background and Overview: Irritable Bowel Syndrome (IBS)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Irritable Bowel Syndrome (IBS) in 7MM
4.3. Total Prevalent/ Incident Patient Population of Irritable Bowel Syndrome (IBS) in 7MM – By Countries
5. Epidemiology of Irritable Bowel Syndrome (IBS) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.1.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) *
5.1.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.1.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.4.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.4.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.4.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.5.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.5.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.5.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.6.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.6.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.6.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.7.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.7.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.7.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.8.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.8.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.8.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS)
5.9.3. Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS)*
5.9.4. Sex- Specific Cases of the Irritable Bowel Syndrome (IBS)*
5.9.5. Diagnosed Cases of the Irritable Bowel Syndrome (IBS)
6. Unmet Needs of the Irritable Bowel Syndrome (IBS)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in 7MM
Table 2: Total Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in United States (2016-2027)*
Table 6: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in France (2016-2027)
Table 12: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in France (2016-2027) *
Table 13: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in France (2016-2027) *
Table 14: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in UK (2016-2027) *
Table 26: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the Irritable Bowel Syndrome (IBS) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the Irritable Bowel Syndrome (IBS) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the Irritable Bowel Syndrome (IBS) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the Irritable Bowel Syndrome (IBS) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us